Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema

Rheumatology (Oxford). 2011 Oct;50(10):1925-6. doi: 10.1093/rheumatology/ker209. Epub 2011 Jun 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Breast Neoplasms / complications
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy
  • Carcinoma, Intraductal, Noninfiltrating / complications
  • Carcinoma, Intraductal, Noninfiltrating / pathology
  • Carcinoma, Intraductal, Noninfiltrating / therapy
  • Combined Modality Therapy
  • Dexamethasone / therapeutic use*
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Middle Aged
  • Remission Induction
  • Scleromyxedema / complications
  • Scleromyxedema / pathology
  • Scleromyxedema / therapy*
  • Skin / pathology
  • Stem Cell Transplantation*
  • Thalidomide / therapeutic use*
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Thalidomide
  • Dexamethasone